P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE

• Maria Agustina Perusini,
• Vikas Gupta,
• Aniket Bankar,
• Jad Sibai,
• Mark Minden,
• Dawn Maze,
• Marta Davidson,
• Guillaume Richard-Carpentier,
• Steven M Chan,
• Andre Schuh,
• Karen Yee,
• Eshetu Atenafu,
• Hassan Sibai

Affiliations

Maria Agustina Perusini

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Vikas Gupta

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Aniket Bankar

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Jad Sibai

2 University of Toronto, Toronto, Canada

Mark Minden

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Dawn Maze

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Marta Davidson

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Guillaume Richard-Carpentier

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Steven M Chan

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Andre Schuh

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Karen Yee

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Eshetu Atenafu

3 University of Toronto, Department of Biostatistics, University Health Network, Toronto, Canada

Hassan Sibai

1 Princess Margaret Cancer Centre, Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada